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A CHANCE ENCOUNTER WITH CILIA
Take my interest in primary cilia. Did I intend to study cilia when I 
started as a postdoctoral fellow with Peter Jackson at Stanford? I did 
not have a clue what a primary cilium was 
back in 2003, so the answer would be a cate-
goric no. Back then, I was set on understand-
ing mitotic exit in mammalian cells. Some 
groundbreaking work had just been published 
on the role of the Cdc14 phosphatase in trig-
gering exit from mitosis in budding yeast, and 
the Jackson lab had initiated a molecular anal-
ysis of the mammalian Cdc14 orthologues. 
But while mitotic exit was clearly a fundamen-
tal and exciting problem, the mammalian 
Cdc14 phosphatases simply would not will-
ingly fit in this pathway. Despite repeated ef-
forts and much hard work, I ended up spend-
ing the better part of a year going nowhere 
(at least scientifically). Then, in the summer of 
2004, an undergraduate student named Trip 
Adler came to the Jackson lab, and it became 
my responsibility to find him a suitable proj-
ect. For lack of a more creative idea, it was 
decided that Trip would conduct a yeast two-
hybrid screen using the Xenopus Cdc14 or-
thologues as baits. A typical day for Trip would 
start with a drive to Santa Cruz at 4 am to surf 
at dawn, followed by a return to the lab at midday to monitor his 
yeast plates and set up some cultures. Somewhat miraculously, we 
completed the two-hybrid screen, and one hit was particularly in-
triguing. Here was a protein named ALMS1, the product of a gene 
mutated in the hereditary disease Alström 
syndrome, which is characterized by obesity, 
retinal degeneration, cardiomyopathy, and 
kidney anomalies. Even though I had never 
been scientifically drawn to the study of hu-
man diseases, I could not help becoming fas-
cinated by a gene product whose dysfunction 
would cause such a constellation of symp-
toms. Still, nothing was known about the mo-
lecular activity of ALMS1 or the etiology of 
Alström syndrome, so I kept puttering along 
on the (dead-end) Cdc14 track.
Nonetheless, I kept trying to get my hands 
on every bit of literature published on this cu-
rious disease. And one day things clicked. An 
article from the Journal of Pediatrics (Michaud 
et al., 1996) made a connection between 
Alström syndrome and Bardet-Biedl syn-
drome (BBS), based on the overlap in symp-
tom presentation. Most excitingly, a couple 
of papers on the localization and possible 
function of BBS proteins in primary cilia had 
just been published (Ansley et al., 2003; 
Blacque et al., 2004; Kim et al., 2004), and 
primary cilia had just been shown to be essential for Hedgehog sig-
naling in mammals (Huangfu et al., 2003). I was hooked and shifted 
direction immediately, trying to understand what makes this little 
organelle so special. Here was an entire organelle about which I and 
nearly all my colleagues knew nothing; it appeared to be essential 
for processing a variety of signals and had been linked to several 
fascinating hereditary disorders. The potential for fundamental as 
well as medically relevant mechanistic advances was enormous. 
Framing a project and getting our first results still took a consider-
able amount of time (we published our discovery of the BBSome, a 
core complex of BBS proteins, in 2007; Nachury et al., 2007), but I 
was confident I had now found a rich niche and all the hard work 
would pay off. I am particularly grateful to the trust given by my 
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advisor Peter Jackson, who gave me the freedom to radically change 
scientific projects during the course of my postdoctoral work.
In hindsight, the odds of tracing such a path from mitotic exit 
to primary cilia seem astronomically low, and such a trajectory 
could never have been planned. Thus, for the most part, it is 
chance that presented me with a novel direction. But necessity 
was also a key ingredient: studying the role of Cdc14A and B in 
mitotic exit was unlikely to yield an important publication, even 
less a faculty position. I was ready for almost any alternative op-
portunity, and when something exciting materialized, nothing was 
there to hold me back.
A CHANCE MOVE TO THE HOME OF MITOTIC SPINDLES
Next, take my work on mitotic spindle assembly. Did I intend to 
work on mitosis or microtubules when starting graduate school? Not 
for a single second. I joined the lab of Karsten Weis (winner of the 
2006 ASCB Early Career Life Scientist Award) with the sole intention 
of studying the role of the GTPase Ran in nucleocytoplasmic trans-
port (Nachury and Weis, 1999). Yet, at the very same time that 
Karsten decided to move his lab from the University of California, 
San Francisco, to Berkeley, where his lab was next to the lab of Re-
becca Heald (winner of the 2005 ASCB Women in Cell Biology 
Junior Award), a string of papers were published that demonstrated 
that Ran itself functioned in mitotic spindle assembly, the central 
theme of Rebecca’s laboratory. How could the timing of Karsten’s 
move have fitted so perfectly with the link between his research and 
Rebecca’s? Pure unadulterated chance, and a phenomenal opportu-
nity for someone halfway through graduate school to work on one 
of the most exciting mechanistic problems in cell biology at the 
time. Figuring out how Ran regulates spindle assembly required 
some creative approaches to dissect the molecular intermediates 
between Ran and microtubules. I benefited from the joint expertise 
of the Weis and Heald labs, which showed me how the whole of a 
collaborative group is much greater than the sum of the individual 
parts. Depleting mitotic extracts with Ran itself and subsequently 
assaying spindle assembly (Nachury et al., 2001) seemed like the 
most natural experiment to do, yet it is highly unlikely such an ex-
periment would have been done if the Weis and Heald labs had not 
been so tightly connected.
CHANCE YIELDS A TRANSFORMATIVE HYPOTHESIS
Finally, take our recent discovery of the tubulin acetyltransferase 
(Shida et al., 2010). My previous studies of the BBSome had 
primed us to consider a role for the BBSome in tubulin acetylation 
(Loktev et al., 2008). But how were we to identify the tubulin 
acetyltransferase? It turned out that the purification of BBSome-
associated proteins from retina recovered one single entity, an 
uncharacterized gene product named C6Orf134. No domains 
were to be found in C6Orf134, and this BBSome-associated pro-
tein was quickly destined for oblivion. Without much hope, I con-
tacted my close collaborator Fernando Bazan (then at Genentech), 
a wizard at uncovering distant similarities between proteins using 
secondary structure–guided alignments. Within 5 min, Fernando 
emailed back that C6Orf134 looked very much like Gcn5, the pro-
totypical histone acetyltransferase! We have since then validated 
C6Orf134 as the tubulin acetyltransferase, but chance played a 
major role in the generation of the hypothesis. If I had not known 
Fernando, none of this work would ever have been initiated.
FINAL THOUGHTS
Don’t be afraid to fail. Failure is part of the scientific progression. 1. 
Most importantly, failure is a temporary condition (“giving up is 
what makes it permanent,” in the words of Marilyn vos Savant). 
Had the project on Cdc14 worked, I would not have been open 
to explore a fundamentally new direction.
Cultivate scientific relationships. “My” best ideas have come 2. 
from open discussions with some phenomenal colleagues. So 
these ideas are not really mine, but they are better ideas be-
cause of it.
Love what you do. Let’s face it, you will earn less (a lot less) than 3. 
your friends who went to law school (or than Trip, who is founder 
and CEO of Scribd, one of the hottest start-ups of 2009). You 
will not become famous (Trip has his own Wikipedia page and 
gets interviewed on NBC, I do not). You are doing science for 
the fun of it. I deeply cherish (and now mostly reminisce about) 
those moments of burning intensity when faced with a novel 
discovery. The times when you look under the microscope and 
utter, “Oh my god…”
Give chance a chance. As trite as this may sound, one has to be 4. 
prepared for the unexpected. Carefully laid out plans may work 
out well for some (they certainly help with getting fundable 
scores on grants), but random events big and small can open up 
horizons one never envisioned.
